|Systematic (IUPAC) name|
|Metabolism||Metabolised via the liver, excreted in the Urine and Feces|
|Excretion||85% of single oral dose is eliminated with 5 days - Urine (63%) and Feces (22%)|
|CAS Registry Number|
|ATC code||G01 J01 P01 QP51|
|(what is this?)|
Ornidazole is a drug that cures some protozoan infections.
2International : Avrazor, Biteral, Borneral, Dazolic, Invigan, Mebaxol, Oniz, Orni, Ornid, Ornidazol Biocrom, Ornidazol Gemepe, Ornidazol Richet, Ornidazole Serb, Ornidazol-Vero, Ornidone, Ornil, Ornisid, Ornitop, Robic, Tiberal, Tibéral, Xynor Why it is prescribed (Indications) :
This medication is an antiamoebic agent, prescribed for amoebic dysentery. When it is not to be taken (Contraindications):
Pregnancy Category :
Category C : Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.
Dosage & When it is to be taken :
PO: Adult- The recommended dose range is 0.5gm to 1.5gm daily for 1 to 7 days.
How it should be taken :
It comes as a tablet to take by mouth as directed by your physician. Warnings and Precautions : Caution should be exercised in patients with history of epilepsy, multiple sclerosis, liver or kidney disease, during pregnancy and breastfeeding.
It may cause dizziness or drowsiness, do not drive a car or operate machinery while taking this medication.
Side Effects :
Central Nervous System- Drowsiness, dizziness, headache, tremor, rigidity, poor coordination, epilepsy, tiredness, temporary loss of consciousness and fainting.
Miscellaneous- Nausea, vomiting, taste disturbances, liver impairment, skin reactions like rash, itching and inflammation.
Other Precautions : Avoid excess dosage. Storage Conditions : Store it at room temperature, and keep away from children.2 
- Rutgeerts P, Van Assche G, Vermeire S et al. (April 2005). "Ornidazole for prophylaxis of postoperative Crohn's disease recurrence: a randomized, double-blind, placebo-controlled trial". Gastroenterology 128 (4): 856–61. doi:10.1053/j.gastro.2005.01.010. PMID 15825069.
|This antiinfective drug article is a stub. You can help Wikipedia by expanding it.|
|This drug article relating to the genito-urinary system is a stub. You can help Wikipedia by expanding it.|